We have located links that may give you full text access.
Adherence to the Mediterranean diet is associated with decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under biological Therapy.
Digestive Diseases 2023 December 2
BACKGROUND AND AIM: Adherence to the Mediterranean diet (MD) was shown to be associated with decreased disease activity in adult patients with Crohn's disease (CD). Nevertheless, data on its association with fecal calprotectin (FC), particularly in children, remain limited. This study aims to assess the association between adherence to the MD and FC as an indicator of mucosal healing (MH), in patients who are predominantly in remission while undergoing biological therapy.
METHODS: This was a cross-sectional study among children with CD. Adherence to MD was evaluated using both the KIDMED questionnaire and a food frequency questionnaire (FFQ). Israeli Mediterranean Diet Adherence Screener (I-MEDAS) score was calculated, and FC samples were obtained.
RESULTS: Of 103 eligible patients, 99 were included (mean age 14.3±2.6 years; 38.4% females); 88% were in clinical remission and 30% presented with elevated FC. The mean KIDMED score was higher among patients who had FC<200 µg/g compared to patients with FC>200µg/g (5.48±2.58 vs. 4.37±2.47, respectively; p=0.04). A moderate correlation between the KIDMED score and the I-MEDAS score was observed (r=0.46; p=0.001). In a multivariate regression analysis, adherence to MD was associated with decreased calprotectin levels, OR 0.75[95%CI: 0.6-0.95], p=0.019. Vegetable consumption was found to be inversely associated with elevated FC (0.9 portion/day [0.3-2.9] in FC>200µg/g vs. 2.2 portions/day [0.87-3.82] in FC<200µg/g; p=0.049).
CONCLUSIONS: In children with CD who are mostly in clinical remission under biological therapy, high adherence to MD is associated with decreased FC levels. Encouraging vegetable consumption, especially during remission, may benefit these patients.
METHODS: This was a cross-sectional study among children with CD. Adherence to MD was evaluated using both the KIDMED questionnaire and a food frequency questionnaire (FFQ). Israeli Mediterranean Diet Adherence Screener (I-MEDAS) score was calculated, and FC samples were obtained.
RESULTS: Of 103 eligible patients, 99 were included (mean age 14.3±2.6 years; 38.4% females); 88% were in clinical remission and 30% presented with elevated FC. The mean KIDMED score was higher among patients who had FC<200 µg/g compared to patients with FC>200µg/g (5.48±2.58 vs. 4.37±2.47, respectively; p=0.04). A moderate correlation between the KIDMED score and the I-MEDAS score was observed (r=0.46; p=0.001). In a multivariate regression analysis, adherence to MD was associated with decreased calprotectin levels, OR 0.75[95%CI: 0.6-0.95], p=0.019. Vegetable consumption was found to be inversely associated with elevated FC (0.9 portion/day [0.3-2.9] in FC>200µg/g vs. 2.2 portions/day [0.87-3.82] in FC<200µg/g; p=0.049).
CONCLUSIONS: In children with CD who are mostly in clinical remission under biological therapy, high adherence to MD is associated with decreased FC levels. Encouraging vegetable consumption, especially during remission, may benefit these patients.
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
Haemodynamic monitoring during noncardiac surgery: past, present, and future.Journal of Clinical Monitoring and Computing 2024 April 31
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app